Check out Kristin Yarema & BioCentury on “Creating CAR T therapies that don’t cause cancer"


Marcea Bland Lloyd, J.D.

Nominating and Corporate Governance Committee Chair

Marcea Bland Lloyd, J.D., serves as chair of the nominating and governance committee and has more than 40 years of executive management, operational and legal experience, predominantly in healthcare. She served as Chief Administrative Officer and General Counsel of Amylin Pharmaceuticals, prior to the company’s acquisition by Bristol-Myers Squibb. She also served as group Senior Vice President, Chief Administrative Officer, General Counsel and Secretary of VHA Inc., a national health care network and spent many years with Medtronic in legal roles including assistant general counsel. Ms. Lloyd is past chairperson of the Executive Leadership Foundation, a former member of the board of directors for California Healthcare Institute and a former associate of the Women Business Leaders of the United States Health Care Industry Foundation. She received a B.S./B.A. from Knox College and a J.D. degree from Northwestern University.